CCND1 and adenoma: We therefore examined the influence of the CCND1 A870G polymorphism on the risk of colorectal cancer and adenoma in three large prospective cohort studies, the Nurses’ Health Study (NHS), the Health Professionals’ Follow-Up Study (HPFS), and the Physicians’ Health Study (PHS).